Loading data...
Loading data...
$38.50 · Score 50/100
0 open-market purchases and 6 sales out of the last 6 Form 4 filings scanned for VCYT — open-market transactions only, sourced directly from official SEC EDGAR filings.
0
Buys
6
Sells
| Date | Insider | Ownership | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Febbo Phillip G. Chief Scientific & Med Officer | — | Open Market Sale | 10,405 | $42.89 | $446.30K |
| Sep 4, 2026 | Chambers Rebecca Chief Financial Officer | — | Open Market Sale | 2,477 | $42.81 | $106.03K |
| Sep 4, 2026 | McGuire Annie EVP, General Counsel | — | Open Market Sale | 2,154 | $42.79 | $92.17K |
| Sep 4, 2026 | Febbo Phillip G. Chief Scientific & Med Officer | — | Open Market Sale | 2,705 | $43.66 | $118.11K |
| Sep 4, 2026 | Chambers Rebecca Chief Financial Officer | — | Open Market Sale | 1,175 | $43.71 | $51.36K |
| Sep 4, 2026 | McGuire Annie EVP, General Counsel | — | Open Market Sale | 1,100 | $43.67 | $48.04K |
This information is based on official filings only and does not constitute investment advice. Insider transactions don't necessarily signal a stock's future direction — they can often stem from personal cash-flow needs, portfolio diversification, or tax planning.